Key facts
- Atapir’s last known valuation is $10.0M (Jun 2024).
- It has raised $5.5M; the latest was Seed Round ($30K) in Feb 2026.
- Notable investors include Fourthwave, Intelligence Ventures.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Atapir
- ·The full record, as it builds
Funding rounds
No funding rounds for Atapir are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Atapir
Developer of an artificial intelligence computer vision software designed to monitor patients without wearables, wires, cuffs, or electrodes. The company's software offers an electronic system that provides sedation for surgical and medical procedures and monitors heart rate, respiratory rate, and pulse oximetry, a non-contact patient monitoring using machine vision and AI, enabling healthcare professionals with a safe, effective, low-cost, low-risk, electronic sedative system.
- Sector
- Healthcare
- HQ
- San Francisco, CA, United States
- Founded
- 2016
- Employees
- 9
- Website
- atapir.com/
- Ownership
- Privately Held (backing)
Atapir doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Atapir shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Atapir in its N-PORT filings yet. We sweep new filings monthly.